Compugen, Inc. Sustainability Profile
Compugen, Inc., a leading biotechnology company headquartered in California, has been at the forefront of immuno-oncology since its establishment in 1998. With a strong presence in North America and Israel, Compugen focuses on the discovery and development of novel therapeutic agents that harness the immune system to combat cancer. The company is renowned for its innovative approach to drug development, particularly its unique computational biology platform that identifies new immune checkpoints and therapeutic targets. Compugen's core products include monoclonal antibodies and immune-modulating therapies, which have shown promise in clinical trials. Recognised for its significant contributions to the field, Compugen has achieved notable milestones, including strategic partnerships with major pharmaceutical companies, solidifying its position as a key player in the biotechnology industry.
DitchCarbon Score
How does Compugen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Compugen, Inc.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Compugen, Inc.'s reported carbon emissions
Compugen, Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures for Scope 1, Scope 2, and Scope 3 emissions. Consequently, there are no verified totals or reduction targets available for the company at this time. In the context of climate commitments, Compugen has not outlined any specific reduction initiatives or targets, nor have they engaged with frameworks such as the Science Based Targets initiative (SBTi) or similar climate pledges. This lack of publicly available data suggests that the company may still be in the early stages of developing its climate strategy or reporting practices. As the industry increasingly prioritises sustainability, Compugen's future commitments and actions will be crucial in aligning with global climate goals.
How Carbon Intensive is Compugen, Inc.'s Industry?
How Carbon Intensive is Compugen, Inc.'s Location?
Compugen, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Compugen, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.